jmb- $2...rumour takeover!, page-5

Vfrioni,

I must have been wrong back then. After all, I actually sold out of them when they dropped back from 40 to 24 in mid-March. I sold @28. I did not like the look of them then due to this whole capitalisation issue, and I do not like them now, for the same reasons.

If I am wrong, then so be it. Everyone make's their own judgements, but the question remains this:
If a company changes its policy from expensing P&D costs to capitalising those costs, what other obvious advantage than a one-off timing advantage is achieved?

In this instance, the timing advantage has obviously boosted profit (expected), and the share price (not expected, as I thought that investors could read the final print detail of the 1/2 year and full year reports).

So, I was wrong back then for reasons associated with people not doing their research, or understanding what it is they are dealing with /investing in.

For a relatively illiquid stock, and with all of the opetions in the money to the tune of $1.30+, why is it that only the CEO has exercised his options so far?

My point - wrong back then, due to a failure to factor for speculative behaviour /herd mentality /the mechanics of an otherwise tightly held stock (after all, 12 months ago, the stock struggled to get to its shareholder spread).

Now - wrong again (time will also tell on this).

I do not, however, hold. Far cheaper, and more attractive stocks elsewhere.